Some Fund Improprieties You May Have Missed
Columbia and Scudder probe timing deals, MFS likely to cut a deal.
Columbia and Scudder probe timing deals, MFS likely to cut a deal.
In September 2003, Eliot Spitzer said the market-timing scandal reflected pervasive problems throughout much of the mutual fund industry. He wasn’t kidding.
Unless you've been living under a rock for the past several months, you've no doubt heard about regulators' investigations of improprieties at firms like Janus, Putnam, and Strong. But other, lower-key revelations continue to surface about dubious trading activity at a number of fund companies. About the only way to keep track of it all is with a scorecard, so we've created one to serve as an easy reference. Click here to read the latest on each scandal-tainted shop in our Fund Industry Investigation Update.
In the meantime, let’s get you caught up on the allegations at some firms that may have flown below your radar. In each case, the potential misdeeds are serious enough that it’s prudent to hold off on making new investments with these firms at least until the complete story is out.
MFSBeyond the scandal, MFS’ record has been mixed. Returns have been average, but the firm was a big fan of incubator funds in the 1990s. Incubator funds are funds that are launched quietly so that they can build a track record. If the record is good, the firm will make the fund available to the general public; if it isn't, they’ll get rid of it. The problem is that this allows firms to exaggerate their stock-picking prowess because you only see their winners.
ScudderScudder also has a mixed record. The firm's most serious lapse occurred a couple of years ago when, according to the SEC, a Deutsche investment banker who did business with Hewlett-Packard (HPQ) leaned on the firm's fund proxy committee to change their votes in support of the HP-Compaq deal. (Deutsche consented to a $750,000 fine, but did not admit or deny the SEC's findings.) Maybe Mr. Spitzer can look into that while he's at it.
Excelsior
Excelsior, a unit of Charles Schwab (SCH), said that previous management had allowed market-timing in eight of its funds. Unfortunately, Excelsior has kept mum on some vital details, such as which funds were timed. The firm said it plans to issue a report on the problems at a later date.
We don’t have other issues with Excelsior’s ethics. As for performance, it’s middling. Excelsior Value & Restructuring is a standout, but some of the other funds have lousy records.
ColumbiaOn the positive side, Columbia’s fund board highlighted a number of improved corporate governance steps that it took. Many were implemented before the scandal broke last September. Specifically, they addressed a key sore point that some fund boards don’t have an independent chairman and that fund boards aren’t getting the complete story from fund companies. In their role of representing fundholders, it’s vital that boards not have a conflict of interest between fundholders and shareholders of the company. So, Columbia named an independent chairman. They also better aligned the funds’ interests with fundholders’ by requiring that investment professionals and trustees hold shares of the funds for a minimum of one year and they doubled the amount that board trustees are required to invest in the funds. They also hired a compliance officer who reports directly to the board. Finally, they added 2% redemption fees to some foreign funds. Those are good first steps. Now if they can just cut those high expenses.
SeligmanOn the whole, Seligman funds’ performance has been unimpressive.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.